Your search returned over 250 results. The top 250 results are being displayed. Please use additional keywords or decrease the search distance.
Your search returned 250 studies:
- Chemotherapy Followed by Allogeneic Stem Cell Transplantation in Treating Children With Hematologic Cancer
Conditions: Leukemia - Lymphoma - Myelodysplastic Syndromes - Myelodysplastic/Myeloproliferative Neoplasms
Location: Bethesda, Maryland
- Genetic Study of Patients With Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Myelodysplastic Syndromes, or Multiple Myeloma
Conditions: Leukemia - Multiple Myeloma and Plasma Cell Neoplasm - Myelodysplastic Syndromes - Myelodysplastic/Myeloproliferative Neoplasms
Location: Baltimore, Maryland
- Genetic Study of Patients With Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Myelodysplastic Syndromes, or Multiple Myeloma
Conditions: Leukemia - Multiple Myeloma and Plasma Cell Neoplasm - Myelodysplastic Syndromes - Myelodysplastic/Myeloproliferative Neoplasms
Location: Elkton MD, Maryland
- Fenretinide in Treating Patients With Refractory or Relapsed Hematologic Cancer
Conditions: Chronic Myeloproliferative Disorders - Leukemia - Lymphoma - Multiple Myeloma and Plasma Cell Neoplasm
Location: Bethesda, Maryland
- Sorafenib in Treating Young Patients With Relapsed or Refractory Solid Tumors or Leukemia
Conditions: Leukemia - Unspecified Childhood Solid Tumor, Protocol Specific
Location: Bethesda, Maryland
- Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Hematologic Cancer or Other Disease
Conditions: Chronic Myeloproliferative Disorders - Graft Versus Host Disease - Leukemia - Lymphoma - Multiple Myeloma and Plasma Cell Neoplasm - Myelodysplastic Syndromes - Myelodysplastic/Myeloproliferative Neoplasms - Secondary Myelofibrosis - Small Intestine Cance
Location: Bethesda, Maryland
- Brain Function in Young Patients Receiving Methotrexate for Acute Lymphoblastic Leukemia
Conditions: Cognitive/Functional Effects - Leukemia - Long-term Effects Secondary to Cancer Therapy in Children - Neurotoxicity - Psychosocial Effects of Cancer and Its Treatment
Location: Baltimore, Maryland
- Collecting and Storing Information From Patients With Cancer or Other Chronic Disease Who Have Undergone Neurobehavioral Assessments on Another Clinic
Conditions: Brain and Central Nervous System Tumors - Cognitive/Functional Effects - Leukemia - Long-term Effects Secondary to Cancer Therapy in Adults - Long-term Effects Secondary to Cancer Therapy in Children - Lymphoma - Metastatic Cancer - Neurofibromatosis Type
Location: Bethesda, Maryland
- Magnetic Acupressure in Reducing Pain in Cancer Patients Undergoing Bone Marrow Aspiration and Biopsy
Conditions: Brain and Central Nervous System Tumors - Chronic Myeloproliferative Disorders - Leukemia - Lymphoma - Lymphoproliferative Disorder - Multiple Myeloma and Plasma Cell Neoplasm - Myelodysplastic Syndromes - Myelodysplastic/Myeloproliferative Neoplasms - Pa
Location: Baltimore, Maryland
- Long-Term Follow-Up of Patients Who Have Participated in Children's Oncology Group Studies
Conditions: Brain and Central Nervous System Tumors - Chronic Myeloproliferative Disorders - Leukemia - Long-term Effects Secondary to Cancer Therapy in Children - Lymphoma - Lymphoproliferative Disorder - Multiple Myeloma and Plasma Cell Neoplasm - Myelodysplastic S
Location: Baltimore, Maryland
- Trial of High Dose Lenalidomide in Patients With Myelodysplastic Syndrome (MDS) and Acute Myeloid Leukemia (AML) With Trilineage Dysplasia (AML-TLD)
Conditions: Myelodysplastic Syndrome
Location: Baltimore, Maryland
- Study of Blood Samples From Newborns With Down Syndrome
Conditions: Leukemia
Location: Baltimore, Maryland
- Clofarabine or Daunorubicin Hydrochloride and Cytarabine Followed By Decitabine or Observation in Treating Older Patients With Newly Diagnosed Acute M
Conditions: Leukemia
Location: Elkton MD, Maryland
- Study to Investigate CAL-101 in Combination With Chemotherapeutic Agents and CD20 mAb in Patients With Relapsed or Refractory Indolent B-cell Non-Hodg
Conditions: Indolent Non-Hodgkin's Lymphoma - Chronic Lymphocytic Leukemia - Mantle Cell Lymphoma
Location: Bethesda, Maryland
- A Trial to Evaluate Two Schedules of MS275 in Combination With 5AC in Elderly Patients With Acute Myeloid Leukemia (AML)
Conditions: Acute Myeloid Leukemia
Location: Baltimore, Maryland
- Phase I Trial to Evaluate the Safety, Activity and Pharmacokinetics of Marqibo(Registered Trademark) (Vincristine Sulfate Liposomes Injection) in Chil
Conditions: Sarcoma - Neuroblastoma - Wilms Tumor - Leukemia - Lymphoma - Brain Tumors
Location: Bethesda, Maryland
- Diagnostic Study of Patients With Acute Lymphoblastic Leukemia or Acute Promyelocytic Leukemia
Conditions: Leukemia
Location: Baltimore, Maryland
- Diagnostic Study of Patients With Acute Lymphoblastic Leukemia or Acute Promyelocytic Leukemia
Conditions: Leukemia
Location: Elkton MD, Maryland
- Pentostatin, Cyclophosphamide, and Rituximab Followed By Lenalidomide in Treating Patients With Relapsed or Refractory B-Cell Chronic Lymphocytic Leuk
Conditions: Leukemia
Location: Elkton MD, Maryland
- Genome Expression in Lymphoma, Leukemia and Multiple Myeloma
Conditions: Lymphoma - Leukemia - Multiple Myeloma - Lymphoid Malignancies
Location: Bethesda, Maryland
- Alemtuzumab (Campath(Registered Trademark)) to Treat T-Large Granular Lymphocyte Leukemia
Conditions: Lymphoproliferative Disorders
Location: Bethesda, Maryland
- Interferon and GM-CSF Compared With Imatinib Mesylate and Vaccine Therapy in Patients With Chronic Phase CML on a TKI
Conditions: Leukemia
Location: Baltimore, Maryland
- Tacrolimus and Methotrexate With or Without Sirolimus in Preventing Graft-Versus-Host Disease in Young Patients Undergoing Donor Stem Cell Transplant
Conditions: Graft Versus Host Disease - Leukemia
Location: Baltimore, Maryland
- S0535, Gemtuzumab and Combination Chemotherapy in Treating Patients With Previously Untreated Acute Promyelocytic Leukemia
Conditions: Leukemia
Location: Baltimore, Maryland
- S0535, Gemtuzumab and Combination Chemotherapy in Treating Patients With Previously Untreated Acute Promyelocytic Leukemia
Conditions: Leukemia
Location: Baltimore, Maryland
- S0535, Gemtuzumab and Combination Chemotherapy in Treating Patients With Previously Untreated Acute Promyelocytic Leukemia
Conditions: Leukemia
Location: Elkton MD, Maryland
- Donor Stem Cell Transplant in Treating Young Patients With Acute Myeloid Leukemia With Monosomy 7, -5/5q-, High FLT3-ITD AR, or Refractory or Relapsed
Conditions: Leukemia
Location: Baltimore, Maryland
- Combination Chemotherapy With or Without Lestaurtinib in Treating Infants With Newly Diagnosed Acute Lymphoblastic Leukemia
Conditions: Leukemia
Location: Baltimore, Maryland
- Combination Chemotherapy With or Without Lestaurtinib in Treating Infants With Newly Diagnosed Acute Lymphoblastic Leukemia
Conditions: Leukemia
Location: Baltimore, Maryland
- Combination Chemotherapy With or Without Lestaurtinib in Treating Infants With Newly Diagnosed Acute Lymphoblastic Leukemia
Conditions: Leukemia
Location: Baltimore, Maryland
- Comparing Three Different Combination Chemotherapy Regimens in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia
Conditions: Adult Acute Basophilic Leukemia - Adult Acute Eosinophilic Leukemia - Adult Acute Megakaryoblastic Leukemia (M7) - Adult Acute Minimally Differentiated Myeloid Leukemia (M0) - Adult Acute Monoblastic Leukemia (M5a) - Adult Acute Monocytic Leukemia (M5b) -
Location: Baltimore, Maryland
- Safety Study of Bone Marrow Transplant Using Mismatched Tissue Followed by Chemotherapy
Conditions: MDS - Leukemias - Lymphomas
Location: Baltimore, Maryland
- Safety Study of Bone Marrow Transplant Using Mismatched Tissue Followed by Chemotherapy
Conditions: MDS - Leukemias - Lymphomas
Location: Baltimore, Maryland
- Mismatched Donor Lymphocyte Infusions for Relapsed Disease Following Allogeneic Stem Cell Transplantation
Conditions: Leukemia, Myeloid, Acute - Leukemia, Lymphoblastic, Acute - Leukemia, Myelocytic, Chronic
Location: Bethesda, Maryland
- Bortezomib and Combination Chemotherapy in Treating Young Patients With Relapsed Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma
Conditions: Leukemia - Lymphoma
Location: Baltimore, Maryland
- Bortezomib and Combination Chemotherapy in Treating Young Patients With Relapsed Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma
Conditions: Leukemia - Lymphoma
Location: Baltimore, Maryland
- Bortezomib and Combination Chemotherapy in Treating Young Patients With Relapsed Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma
Conditions: Leukemia - Lymphoma
Location: Bethesda, Maryland
- Collecting and Storing Samples of Bone Marrow and Blood From Patients With Relapsed Acute Lymphoblastic Leukemia or Non-Hodgkin Lymphoma
Conditions: Leukemia - Lymphoma
Location: Baltimore, Maryland
- Collecting and Storing Samples of Bone Marrow and Blood From Patients With Relapsed Acute Lymphoblastic Leukemia or Non-Hodgkin Lymphoma
Conditions: Leukemia - Lymphoma
Location: Baltimore, Maryland
- Collecting and Storing Samples of Bone Marrow and Blood From Patients With Relapsed Acute Lymphoblastic Leukemia or Non-Hodgkin Lymphoma
Conditions: Leukemia - Lymphoma
Location: Baltimore, Maryland
- Collecting and Storing Samples of Bone Marrow and Blood From Patients With Relapsed Acute Lymphoblastic Leukemia or Non-Hodgkin Lymphoma
Conditions: Leukemia - Lymphoma
Location: Bethesda, Maryland
- Collecting Tissue Samples From Patients With Leukemia or Other Blood Disorders Planning to Enroll in an ECOG Leukemia Treatment Clinical Trial
Conditions: Leukemia - Lymphoma
Location: Baltimore, Maryland
- Collecting Tissue Samples From Patients With Leukemia or Other Blood Disorders Planning to Enroll in an ECOG Leukemia Treatment Clinical Trial
Conditions: Leukemia - Lymphoma
Location: Elkton MD, Maryland
- Collecting and Storing Malignant, Borderline Malignant Neoplasms, and Related Samples From Young Patients With Cancer
Conditions: Leukemia - Neoplasm of Uncertain Malignant Potential - Unspecified Childhood Solid Tumor, Protocol Specific
Location: Baltimore, Maryland
- Collecting and Storing Malignant, Borderline Malignant Neoplasms, and Related Samples From Young Patients With Cancer
Conditions: Leukemia - Neoplasm of Uncertain Malignant Potential - Unspecified Childhood Solid Tumor, Protocol Specific
Location: Bethesda, Maryland
- Collecting and Storing Blood, Bone Marrow, and Other Samples From Patients With Acute Leukemia, Chronic Leukemia, or Myelodysplastic Syndromes
Conditions: Leukemia - Lymphoma - Myelodysplastic Syndromes - Myelodysplastic/Myeloproliferative Neoplasms
Location: Baltimore, Maryland
- Collecting and Storing Blood, Bone Marrow, and Other Samples From Patients With Acute Leukemia, Chronic Leukemia, or Myelodysplastic Syndromes
Conditions: Leukemia - Lymphoma - Myelodysplastic Syndromes - Myelodysplastic/Myeloproliferative Neoplasms
Location: Bethesda, Maryland
- Collecting and Storing Blood, Bone Marrow, and Other Samples From Patients With Acute Leukemia, Chronic Leukemia, or Myelodysplastic Syndromes
Conditions: Leukemia - Lymphoma - Myelodysplastic Syndromes - Myelodysplastic/Myeloproliferative Neoplasms
Location: Elkton MD, Maryland
- Studying Tissue and Blood Samples From Patients With Acute Myeloid Leukemia
Conditions: Leukemia
Location: Baltimore, Maryland
- Studying Tissue and Blood Samples From Patients With Acute Myeloid Leukemia
Conditions: Leukemia
Location: Elkton MD, Maryland
- Panobinostat and Everolimus in Treating Patients With Recurrent Multiple Myeloma, Non-Hodgkin Lymphoma, or Hodgkin Lymphoma
Conditions: Hematopoietic/Lymphoid Cancer - Adult Nasal Type Extranodal NK/T-cell Lymphoma - Anaplastic Large Cell Lymphoma - Angioimmunoblastic T-cell Lymphoma - B-cell Adult Acute Lymphoblastic Leukemia - Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associate
Location: Bethesda, Maryland
- Cladribine With Simultaneous or Delayed Rituximab to Treat Hairy Cell Leukemia
Conditions: Hairy Cell Leukemia
Location: Bethesda, Maryland
- Natural History Study of Monoclonal B Cell Lymphocytosis and Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
Conditions: B-Cell Chronic Lymphocytic Leukemia - Monoclonal B-Cell Lymphocytosis - Lymhoma, Small Lymphocytic - Chronic Lymphocytic Leukemia
Location: Bethesda, Maryland
- Wilm's Tumor 1 Protein Vaccine to Treat Cancers of the Blood
Conditions: Leukemia, Acute Myelogenous (AML) - Leukemia, Acute Lymphocytic (ALL) - Leukemia, Chronic Myelogenous (CML) - Myelodysplastic Syndrome (MDS) - Non-Hodgkin's Lymphoma (NHL)
Location: Bethesda, Maryland
- Bortezomib and Romidepsin in Treating Patients With Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Indolent B-cell Lymphoma, Peripheral T-c
Conditions: Leukemia - Lymphoma
Location: Baltimore, Maryland
- Pilot Trial of Targeted Immune-Depleting Chemotherapy and Reduced-Intensity Matched Unrelated Double Cord Blood Transplant for the Treatment of Leukem
Conditions: Leukemia - Non-Hodgkins Lymphoma - Hodgkins Lymphoma - MDS - Multiple Myeloma
Location: Bethesda, Maryland
- Pilot Study of Radiation-Enhanced Allogeneic Cell Therapy for Progressive Hematologic Malignancy After Allogeneic Hematopoietic Stem Cell Transplantat
Conditions: Hodgkin's Lymphoma - Non-Hodgkin's Lymphoma - Chronic Lymphocytic Leukemias - Multiple Myeloma With Plasmacytoma
Location: Bethesda, Maryland
- EPOCH Chemotherapy and Bortezomib for Associated T-Cell Leukemia Lymphoma
Conditions: Leukemia-Lymphoma, Adult T-Cell
Location: Baltimore, Maryland
- Study of Biomarkers in Blood and Bone Marrow Samples From Patients With Previously Untreated Chronic Lymphocytic Leukemia
Conditions: Leukemia
Location: Bethesda, Maryland
- Study of Biomarkers in Blood and Bone Marrow Samples From Patients With Previously Untreated Chronic Lymphocytic Leukemia
Conditions: Leukemia
Location: Elkton MD, Maryland
- Donor Stem Cell Transplant in Treating Patients With High-Risk Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
Conditions: Leukemia - Lymphoma
Location: Elkton MD, Maryland
- Evaluation of a New Anti-cancer Immunotherapy in Adult Acute Myeloid Leukemia Patients With a Suboptimal Clinical Response to Induction Chemotherapy
Conditions: WT1-positive Acute Myeloid Leukemia - Leukaemia, Myelocytic, Acute
Location: Baltimore, Maryland
- Randomized Phase II Trial of Rituximab With Either Pentostatin or Bendamustine for Multiply Relapsed or Refractory Hairy Cell Leukemia
Conditions: Hairy Cell Leukemia
Location: Bethesda, Maryland
- Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Conditions: Chronic Lymphocytic Leukemia
Location: Westminster, Maryland
- Collection of Human Samples to Study Hairy Cell and Other Leukemias, and to Develop Recombinant Immunotoxins for Cancer Treatment
Conditions: Hairy Cell Leukemia (HCL) - Chronic Lymphocytic Leukemia (CLL) - Non-Hodgkins Lymphoma (NHL) - Cutaneous T Cell Lymphoma (CTCL) - Adult T Cell Lymphoma (ATL)
Location: Bethesda, Maryland
- An Extension Study for Patients Who Are Deriving Benefit With CAL-101 to Continue on Treatment at the End of the Current Study
Conditions: Chronic Lymphocytic Leukemia - Lymphoma, Non-Hodgkin - Acute Myeloid Leukemia - Multiple Myeloma
Location: Bethesda, Maryland
- A Study of the Kinetics of Lymphoid Cells in Patients With Monoclonal B-cell Lymphocytosis (MBL), Chronic Lymphocytic Leukemia (CLL) or Small Lymphocy
Conditions: Monoclonal B-Cell Lymphocytosis
Location: Bethesda, Maryland
- Enrollment on the Childhood Cancer Research Network (CCRN) of the Children's Oncology Group
Conditions: Pediatric Cancer - Leukemia - Sarcoma - Brain Tumors
Location: Bethesda, Maryland
- First in Human Study to Determine the Safety, Tolerability and Preliminary Efficacy of an Anti-CXCR4 Antibody in Subjects With Acute Myelogenous Leuke
Conditions: Acute Myelogenous Leukemia - Diffuse Large B-Cell Leukemia - Chronic Lymphocytic Leukemia - Follicular Lymphoma
Location: Baltimore, Maryland
- Veliparib and Temozolomide in Treating Patients With Acute Leukemia
Conditions: Accelerated Phase Chronic Myelogenous Leukemia - Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic Syndrome - Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities - Adult Acute Myeloid Leukemia With Del(5q) - Adult Acute
Location: Baltimore, Maryland
- Risk-Based Classification System of Patients With Newly Diagnosed Acute Lymphoblastic Leukemia
Conditions: Leukemia
Location: Baltimore, Maryland
- Risk-Based Classification System of Patients With Newly Diagnosed Acute Lymphoblastic Leukemia
Conditions: Leukemia
Location: Baltimore, Maryland
- Risk-Based Classification System of Patients With Newly Diagnosed Acute Lymphoblastic Leukemia
Conditions: Leukemia
Location: Baltimore, Maryland
- Risk-Based Classification System of Patients With Newly Diagnosed Acute Lymphoblastic Leukemia
Conditions: Leukemia
Location: Bethesda, Maryland
- A Phase II Study of Ofatumumab-Based Induction Chemoimmunotheraphy Followed by Consolidation Ofatumumab Immunotherapy in Previously Untreated Patients
Conditions: Small Lymphocytic Lymphoma - CLL (Chronic Lymphocytic Leukemia)
Location: Bethesda, Maryland
- MLN8237 in Treating Young Patients With Recurrent or Refractory Solid Tumors or Leukemia
Conditions: Brain and Central Nervous System Tumors - Childhood Germ Cell Tumor - Kidney Cancer - Leukemia - Liver Cancer - Neuroblastoma - Sarcoma
Location: Baltimore, Maryland
- MLN8237 in Treating Young Patients With Recurrent or Refractory Solid Tumors or Leukemia
Conditions: Brain and Central Nervous System Tumors - Childhood Germ Cell Tumor - Kidney Cancer - Leukemia - Liver Cancer - Neuroblastoma - Sarcoma
Location: Baltimore, Maryland
- INCB18424 in Treating Young Patients With Relapsed or Refractory Solid Tumor, Leukemia, or Myeloproliferative Disease
Conditions: Chronic Myeloproliferative Disorders - Leukemia - Myelodysplastic Syndromes - Myelodysplastic/Myeloproliferative Neoplasms - Unspecified Childhood Solid Tumor, Protocol Specific
Location: Baltimore, Maryland
- INCB18424 in Treating Young Patients With Relapsed or Refractory Solid Tumor, Leukemia, or Myeloproliferative Disease
Conditions: Chronic Myeloproliferative Disorders - Leukemia - Myelodysplastic Syndromes - Myelodysplastic/Myeloproliferative Neoplasms - Unspecified Childhood Solid Tumor, Protocol Specific
Location: Bethesda, Maryland
- Risk-Adapted Chemotherapy in Younger Patients With Newly Diagnosed Standard-Risk Acute Lymphoblastic Leukemia
Conditions: Leukemia
Location: Baltimore, Maryland
- Risk-Adapted Chemotherapy in Younger Patients With Newly Diagnosed Standard-Risk Acute Lymphoblastic Leukemia
Conditions: Leukemia
Location: Baltimore, Maryland
- Risk-Adapted Chemotherapy in Younger Patients With Newly Diagnosed Standard-Risk Acute Lymphoblastic Leukemia
Conditions: Leukemia
Location: Baltimore, Maryland
- Risk-Adapted Chemotherapy in Younger Patients With Newly Diagnosed Standard-Risk Acute Lymphoblastic Leukemia
Conditions: Leukemia
Location: Bethesda, Maryland
- To Evaluate the Safety, Activity and Pharmacokinetics of Marqibo in Children and Adolescents With Refractory Cancer
Conditions: Sarcoma - Neuroblastoma - Wilms Tumor - Leukemia - Lymphoma - Brain Tumors
Location: Bethesda, Maryland
- CMR Rate of Newly Diagnosed CML-CP Patients Treated With Nilotinib
Conditions: Chronic Myelogenous Leukemia in Chronic Phase
Location: Baltimore, Maryland
- Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting
Conditions: Chronic Myeloid Leukemia
Location: Columbia, Maryland
- A Study of Oral Sapacitabine in Elderly Patients With Newly Diagnosed Acute Myeloid Leukemia
Conditions: Acute Myeloid Leukemia
Location: Baltimore, Maryland
- Caspofungin Acetate or Fluconazole in Preventing Invasive Fungal Infections in Patients With Acute Myeloid Leukemia Who Are Undergoing Chemotherapy
Conditions: Fungal Infection - Leukemia - Neutropenia
Location: Baltimore, Maryland
- Caspofungin Acetate or Fluconazole in Preventing Invasive Fungal Infections in Patients With Acute Myeloid Leukemia Who Are Undergoing Chemotherapy
Conditions: Fungal Infection - Leukemia - Neutropenia
Location: Baltimore, Maryland
- POETIC Plerixafor as a Chemosensitizing Agent for Relapsed Acute Leukemia and MDS in Pediatric Patients
Conditions: Relapsed/Refractory AML - Relapsed/Refractory ALL - Secondary AML/MDS - Acute Leukemia of Ambiguous Lineage - AML - ALL
Location: Baltimore, Maryland
- Relapsed Malignant Blood Cancer After Allogeneic Hematopoietic Stem Cell Transplantation
Conditions: Chronic Myelogenous Leukemia - Acute Myelogenous Leukemia - Acute Lymphoblastic Leukemia - Hodgkins Lymphoma - Non-Hodgkins Lymphoma
Location: Bethesda, Maryland
- Shorter Course Tacrolimus After Nonmyeloablative, Related Donor BMT With High-dose Posttransplantation Cyclophosphamide
Conditions: Hodgkin's Lymphoma - Leukemia - Myelodysplastic Syndrome(MDS) - Multiple Myeloma - Non Hodgkin's Lymphoma
Location: Baltimore, Maryland
- Phase 1/2 Safety and Efficacy of PLX3397 in Adults With Relapsed or Refractory Acute Myeloid Leukemia (AML)
Conditions: Acute Myeloid Leukemia
Location: Baltimore, Maryland
- Alvocidib, Cytarabine, and Mitoxantrone Hydrochloride or Cytarabine and Daunorubicin Hydrochloride in Treating Patients With Newly Diagnosed Acute Mye
Conditions: Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic Syndrome - Adult Acute Minimally Differentiated Myeloid Leukemia (M0) - Adult Acute Monoblastic Leukemia (M5a) - Adult Acute Monocytic Leukemia (M5b) - Adult Acute Myeloblastic L
Location: Baltimore, Maryland
- Alvocidib, Cytarabine, and Mitoxantrone Hydrochloride or Cytarabine and Daunorubicin Hydrochloride in Treating Patients With Newly Diagnosed Acute Mye
Conditions: Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic Syndrome - Adult Acute Minimally Differentiated Myeloid Leukemia (M0) - Adult Acute Monoblastic Leukemia (M5a) - Adult Acute Monocytic Leukemia (M5b) - Adult Acute Myeloblastic L
Location: Baltimore, Maryland
- Zarnestra in Newly Diagnosed Acute Myelogenous Leukemia (AML)With 2 Gene Expression Signature Ratio
Conditions: Acute Myelogenous Leukemia
Location: Baltimore, Maryland
- Zarnestra in Newly Diagnosed Acute Myelogenous Leukemia (AML)With 2 Gene Expression Signature Ratio
Conditions: Acute Myelogenous Leukemia
Location: Baltimore, Maryland
- Levofloxacin in Preventing Infection in Young Patients Receiving Chemotherapy For Acute Leukemia or Undergoing Stem Cell Transplantation
Conditions: Bacterial Infection - Leukemia - Musculoskeletal Complications - Neutropenia
Location: Baltimore, Maryland
- Levofloxacin in Preventing Infection in Young Patients Receiving Chemotherapy For Acute Leukemia or Undergoing Stem Cell Transplantation
Conditions: Bacterial Infection - Leukemia - Musculoskeletal Complications - Neutropenia
Location: Baltimore, Maryland
- Bortezomib and Sorafenib Tosylate in Patients With Newly Diagnosed Acute Myeloid Leukemia With or Without Mutations
Conditions: Adult Acute Erythroid Leukemia (M6) - Adult Acute Megakaryoblastic Leukemia (M7) - Adult Acute Minimally Differentiated Myeloid Leukemia (M0) - Adult Acute Monoblastic Leukemia (M5a) - Adult Acute Monocytic Leukemia (M5b) - Adult Acute Myeloblastic Leukem
Location: Baltimore, Maryland
- Bortezomib and Sorafenib Tosylate in Patients With Newly Diagnosed Acute Myeloid Leukemia With or Without Mutations
Conditions: Adult Acute Erythroid Leukemia (M6) - Adult Acute Megakaryoblastic Leukemia (M7) - Adult Acute Minimally Differentiated Myeloid Leukemia (M0) - Adult Acute Monoblastic Leukemia (M5a) - Adult Acute Monocytic Leukemia (M5b) - Adult Acute Myeloblastic Leukem
Location: Baltimore, Maryland
- Bortezomib and Sorafenib Tosylate in Patients With Newly Diagnosed Acute Myeloid Leukemia With or Without Mutations
Conditions: Adult Acute Erythroid Leukemia (M6) - Adult Acute Megakaryoblastic Leukemia (M7) - Adult Acute Minimally Differentiated Myeloid Leukemia (M0) - Adult Acute Monoblastic Leukemia (M5a) - Adult Acute Monocytic Leukemia (M5b) - Adult Acute Myeloblastic Leukem
Location: Baltimore, Maryland
- MRD Testing Before and After Hematopoietic Cell Transplantation Transplantation for Pediatric Acute Myeloid Leukemia
Conditions: Acute Myeloid Leukemia
Location: Baltimore, Maryland
- A Study to Assess AC220 Given in Combination With Induction and Consolidation Therapy in Newly Diagnosed Acute Myeloid Leukemia (AML)
Conditions: Leukemia, Myeloid, Acute
Location: Baltimore, Maryland
- Combination Chemotherapy in Treating Young Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia
Conditions: Cognitive/Functional Effects - Leukemia - Neurotoxicity - Pain - Therapy-related Toxicity
Location: Baltimore, Maryland
- Combination Chemotherapy in Treating Young Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia
Conditions: Cognitive/Functional Effects - Leukemia - Neurotoxicity - Pain - Therapy-related Toxicity
Location: Baltimore, Maryland
- Combination Chemotherapy in Treating Young Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia
Conditions: Cognitive/Functional Effects - Leukemia - Neurotoxicity - Pain - Therapy-related Toxicity
Location: Baltimore, Maryland
- Combination Chemotherapy in Treating Young Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia
Conditions: Cognitive/Functional Effects - Leukemia - Neurotoxicity - Pain - Therapy-related Toxicity
Location: Bethesda, Maryland
- Decitabine With or Without Bortezomib in Treating Older Patients With Acute Myeloid Leukemia
Conditions: Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic Syndrome - Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities - Adult Acute Myeloid Leukemia With Del(5q) - Adult Acute Myeloid Leukemia With t(16;16)(p13;q22) - Seconda
Location: Elkton MD, Maryland
- Clinical, Laboratory and Epidemiologic Characterization of Individuals and Families at High Risk of Hematologic Cancer
Conditions: Lymphoma - Leukemia
Location: Bethesda, Maryland
- Study of MK-8242 Alone and in Combination With Cytarabine in Participants With Acute Myelogenous Leukemia (P07649 AM3)
Conditions: Acute Myelogenous Leukemia (AML)
Location: Baltimore, Maryland
- Alisertib in Treating Patients With Relapsed or Refractory Peripheral T-Cell Non-Hodgkin Lymphoma
Conditions: Adult Nasal Type Extranodal NK/T-cell Lymphoma - Anaplastic Large Cell Lymphoma - Angioimmunoblastic T-cell Lymphoma - Hepatosplenic T-cell Lymphoma - Peripheral T-cell Lymphoma - Recurrent Adult Non-Hodgkin Lymphoma - Recurrent Adult T-cell Leukemia/Lymp
Location: Elkton MD, Maryland
- PCI-32765 for Special Cases of Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
Conditions: Leukemia - Leukemia, Lymphocytyc - CLL (Chronic Lymphocytic Leukemia) - SLL (Small Lymphocytic Lymphoma)
Location: Bethesda, Maryland
- Improving Blood Stem Cell Collection and Transplant Procedures
Conditions: Myelodysplastic Syndrome (MDS) - Chronic Myelogenous Leukemia - Acute Lymphoblastic Leukemia - CML (Chronic Myelogenous Leukemia - CLL (Chronic Lymphocytic Leukemia) - Acute Myeloid Leukemia (AML)
Location: Bethesda, Maryland
- Evaluation, Treatment, and Natural History of Children With Cancer
Conditions: Ewing's Sarcoma - Leukemia - Lymphoma - Neoplasm - Sarcoma
Location: Bethesda, Maryland
- Studying Blood Toxicity in Workers Exposed to Formaldehyde
Conditions: Formaldehyde - Hematotoxicity - Leukemia
Location: Bethesda, Maryland
- Sorafenib Tosylate Before and After Donor Bone Marrow Transplantation in Treating Patients With Acute Myeloid Leukemia
Conditions: Leukemia
Location: Baltimore, Maryland
- Safety Study of Anti-Programmed Death-1 in Hematologic Malignancy
Conditions: Non-Hodgkin's Lymphoma - Hodgkin Lymphoma - Multiple Myeloma - Chronic Myelogenous Leukemia
Location: Baltimore, Maryland
- Combination Chemotherapy With or Without Rituximab in Treating Younger Patients With Stage III-IV Non-Hodgkin Lymphoma or B-Cell Acute Leukemia
Conditions: Leukemia - Lymphoma
Location: Baltimore, Maryland
- Double Cord Versus Haploidentical (Blood and Marrow Transplant Clinical Trials Network #1101)
Conditions: Acute Lymphocytic Leukemia - Acute Myelogenous Leukemia - Burkitt's Lymphoma - Follicular Lymphoma - Hodgkin Lymphoma - Mantle Cell Lymphoma
Location: Baltimore, Maryland
- Cediranib Maleate in Treating Patients With Relapsed, Refractory, or Untreated Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome
Conditions: Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities - Adult Acute Myeloid Leukemia With Inv(16)(p13;q22) - Adult Acute Myeloid Leukemia With t(15;17)(q22;q12) - Adult Acute Myeloid Leukemia With t(16;16)(p13;q22) - Adult Acute Myeloid Leukemia Wit
Location: Baltimore, Maryland
- Sorafenib in Treating Young Patients With Relapsed or Refractory Solid Tumors or Leukemia
Conditions: Blastic Phase Chronic Myelogenous Leukemia - Childhood Acute Promyelocytic Leukemia (M3) - Childhood Chronic Myelogenous Leukemia - Chronic Myelogenous Leukemia, BCR-ABL1 Positive - Juvenile Myelomonocytic Leukemia - Philadelphia Chromosome Negative Chron
Location: Bethesda, Maryland
- A Randomized, Controlled Study Evaluating the Efficacy and Safety of GS-1101 (CAL-101) in Combination With Ofatumumab for Previously Treated Chronic L
Conditions: Chronic Lymphocytic Leukemia
Location: Bethesda, Maryland
- Tissue Collection for Studies of Lymph Cancer
Conditions: Hodgkin Disease - Lymphoma, Non-Hodgkin - Multiple Myeloma - Lymphomatoid Granulomatosis - Leukemia-Lymphoma, Adult T-Cell
Location: Bethesda, Maryland
- A Phase 1 Trial of TST of PD 0332991 Followed by Cytarabine and Mitoxantrone for Adults With Relapsed and Refractory Acute Leukemias and High-Risk Mye
Conditions: Relapsed Acute Leukemia - Refractory Acute Leukemia - High-Risk Myelodysplasia
Location: Baltimore, Maryland
- Ruxolitinib for Adult T-Cell Leukemia
Conditions: T Cell Leukemia, Adult - Leukemia, Adult T-Cell - T Cell Leukemia, HTLV I Associated
Location: Bethesda, Maryland
- Ublituximab in Combination With Lenalidomide in Patients With B-Cell Lymphoid Malignancies
Conditions: Non-Hodgkins Lymphoma - Chronic Lymphocytic Leukemia - Small Lymphocytic Lymphoma - B-cell Lymphomas - Marginal Zone Lymphoma - Mantle Cell Lymphoma - Waldenstrom's Macroglobulinemia
Location: Bethesda, Maryland
- Ipilimumab in Treating Patients With Relapsed or Refractory High-Risk Myelodysplastic Syndrome or Acute Myeloid Leukemia
Conditions: Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities - Adult Acute Myeloid Leukemia With Del(5q) - Adult Acute Myeloid Leukemia With Inv(16)(p13;q22) - Adult Acute Myeloid Leukemia With t(15;17)(q22;q12) - Adult Acute Myeloid Leukemia With t(16;16)
Location: Baltimore, Maryland
- Genetic Study of Patients With Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Myelodysplastic Syndromes, or Multiple Myeloma
Conditions: Leukemia - Multiple Myeloma and Plasma Cell Neoplasm - Myelodysplastic Syndromes - Myelodysplastic/Myeloproliferative Neoplasms
Location: Washington, District of Columbia
- Study to Assess Compliance With Long-Term Mercaptopurine Treatment in Young Patients With Acute Lymphoblastic Leukemia in Remission
Conditions: Leukemia
Location: Falls Church, Virginia
- Study to Assess Compliance With Long-Term Mercaptopurine Treatment in Young Patients With Acute Lymphoblastic Leukemia in Remission
Conditions: Leukemia
Location: Washington, District of Columbia
- Study to Assess Compliance With Long-Term Mercaptopurine Treatment in Young Patients With Acute Lymphoblastic Leukemia in Remission
Conditions: Leukemia
Location: Washington, District of Columbia
- LMB-2 to Treat Hairy Cell Leukemia
Conditions: Positive Hairy Cell Leukemia - CD25-Expressing Hairy Cell Leukemia
Location: Bethesda, Maryland
- Low-Dose or High-Dose Vincristine and Combination Chemotherapy in Treating Young Patients With Relapsed B-Cell Acute Lymphoblastic Leukemia
Conditions: Leukemia
Location: Baltimore, Maryland
- Low-Dose or High-Dose Vincristine and Combination Chemotherapy in Treating Young Patients With Relapsed B-Cell Acute Lymphoblastic Leukemia
Conditions: Leukemia
Location: Baltimore, Maryland
- Low-Dose or High-Dose Vincristine and Combination Chemotherapy in Treating Young Patients With Relapsed B-Cell Acute Lymphoblastic Leukemia
Conditions: Leukemia
Location: Baltimore, Maryland
- Low-Dose or High-Dose Vincristine and Combination Chemotherapy in Treating Young Patients With Relapsed B-Cell Acute Lymphoblastic Leukemia
Conditions: Leukemia
Location: Bethesda, Maryland
- Combination Chemotherapy in Treating Young Patients With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia or T-cell Lymphoblastic Lymphoma
Conditions: Contiguous Stage II Adult Lymphoblastic Lymphoma - Noncontiguous Stage II Adult Lymphoblastic Lymphoma - Stage II Adult T-cell Leukemia/Lymphoma - Stage II Childhood Lymphoblastic Lymphoma - Stage III Adult Lymphoblastic Lymphoma - Stage III Adult T-cell
Location: Falls Church, Virginia
- Combination Chemotherapy in Treating Young Patients With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia or T-cell Lymphoblastic Lymphoma
Conditions: Contiguous Stage II Adult Lymphoblastic Lymphoma - Noncontiguous Stage II Adult Lymphoblastic Lymphoma - Stage II Adult T-cell Leukemia/Lymphoma - Stage II Childhood Lymphoblastic Lymphoma - Stage III Adult Lymphoblastic Lymphoma - Stage III Adult T-cell
Location: Baltimore, Maryland
- Combination Chemotherapy in Treating Young Patients With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia or T-cell Lymphoblastic Lymphoma
Conditions: Contiguous Stage II Adult Lymphoblastic Lymphoma - Noncontiguous Stage II Adult Lymphoblastic Lymphoma - Stage II Adult T-cell Leukemia/Lymphoma - Stage II Childhood Lymphoblastic Lymphoma - Stage III Adult Lymphoblastic Lymphoma - Stage III Adult T-cell
Location: Baltimore, Maryland
- Combination Chemotherapy in Treating Young Patients With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia or T-cell Lymphoblastic Lymphoma
Conditions: Contiguous Stage II Adult Lymphoblastic Lymphoma - Noncontiguous Stage II Adult Lymphoblastic Lymphoma - Stage II Adult T-cell Leukemia/Lymphoma - Stage II Childhood Lymphoblastic Lymphoma - Stage III Adult Lymphoblastic Lymphoma - Stage III Adult T-cell
Location: Baltimore, Maryland
- Combination Chemotherapy in Treating Young Patients With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia or T-cell Lymphoblastic Lymphoma
Conditions: Contiguous Stage II Adult Lymphoblastic Lymphoma - Noncontiguous Stage II Adult Lymphoblastic Lymphoma - Stage II Adult T-cell Leukemia/Lymphoma - Stage II Childhood Lymphoblastic Lymphoma - Stage III Adult Lymphoblastic Lymphoma - Stage III Adult T-cell
Location: Bethesda, Maryland
- Brain Function in Young Patients Receiving Methotrexate for Acute Lymphoblastic Leukemia
Conditions: Cognitive/Functional Effects - Leukemia - Long-term Effects Secondary to Cancer Therapy in Children - Neurotoxicity - Psychosocial Effects of Cancer and Its Treatment
Location: Washington, District of Columbia
- Chemotherapy and Unrelated Donor Stem Cell Transplantation for Patients With Cancers of the Blood and Immune System
Conditions: Myelodysplastic Syndrome - Hodgkin's Lymphoma - Non-Hodgkin's Disease - Acute Leukemia - Multiple Myeloma
Location: Bethesda, Maryland
- Combination Chemotherapy With or Without Lestaurtinib in Treating Infants With Newly Diagnosed Acute Lymphoblastic Leukemia
Conditions: Leukemia
Location: Falls Church, Virginia
- A Phase I, Multicenter Dose Escalation Study in Patients With Leukemia
Conditions: Hairy Cell Leukemia
Location: Bethesda, Maryland
- Veliparib and Topotecan With or Without Carboplatin in Treating Patients With Relapsed or Refractory Acute Leukemia, High-Risk Myelodysplasia, or Aggr
Conditions: Adult Acute Megakaryoblastic Leukemia (M7) - Adult Acute Minimally Differentiated Myeloid Leukemia (M0) - Adult Acute Monoblastic Leukemia (M5a) - Adult Acute Monocytic Leukemia (M5b) - Adult Acute Myeloblastic Leukemia With Maturation (M2) - Adult Acute
Location: Baltimore, Maryland
- CAT-8015 in Children, Adolescents and Young Adults With Acute Lymphoblastic Leukemia or Non-Hodgkin's Lymphoma
Conditions: Acute Lymphoblastic Leukemia - Non-Hodgkin's Lymphoma
Location: Bethesda, Maryland
- Natural Killer Cells and Bortezomib to Treat Cancer
Conditions: Lung or Prostatic Neoplasms - Colorectal or Kidney Neoplasms - Pancreatic Neoplasms - Leukemia, Myelogenous, Chronic Lymphocytic Leukemia, BCR-ABL Positive - Melanoma - CLL
Location: Bethesda, Maryland
- Long-Term Follow-Up of Patients Who Have Participated in Children's Oncology Group Studies
Conditions: Brain and Central Nervous System Tumors - Chronic Myeloproliferative Disorders - Leukemia - Long-term Effects Secondary to Cancer Therapy in Children - Lymphoma - Lymphoproliferative Disorder - Multiple Myeloma and Plasma Cell Neoplasm - Myelodysplastic S
Location: Washington, District of Columbia
- Long-Term Follow-Up of Patients Who Have Participated in Children's Oncology Group Studies
Conditions: Brain and Central Nervous System Tumors - Chronic Myeloproliferative Disorders - Leukemia - Long-term Effects Secondary to Cancer Therapy in Children - Lymphoma - Lymphoproliferative Disorder - Multiple Myeloma and Plasma Cell Neoplasm - Myelodysplastic S
Location: Washington, District of Columbia
- Long-Term Follow-Up of Patients Who Have Participated in Children's Oncology Group Studies
Conditions: Brain and Central Nervous System Tumors - Chronic Myeloproliferative Disorders - Leukemia - Long-term Effects Secondary to Cancer Therapy in Children - Lymphoma - Lymphoproliferative Disorder - Multiple Myeloma and Plasma Cell Neoplasm - Myelodysplastic S
Location: Washington, District of Columbia
- Combination Chemotherapy With or Without Donor Stem Cell Transplant in Treating Patients With Acute Lymphoblastic Leukemia
Conditions: Adult Acute Lymphoblastic Leukemia in Remission - B-cell Adult Acute Lymphoblastic Leukemia - L1 Adult Acute Lymphoblastic Leukemia - L2 Adult Acute Lymphoblastic Leukemia - Philadelphia Chromosome Positive Adult Precursor Acute Lymphoblastic Leukemia - R
Location: Baltimore, Maryland
- Combination Chemotherapy With or Without Donor Stem Cell Transplant in Treating Patients With Acute Lymphoblastic Leukemia
Conditions: Adult Acute Lymphoblastic Leukemia in Remission - B-cell Adult Acute Lymphoblastic Leukemia - L1 Adult Acute Lymphoblastic Leukemia - L2 Adult Acute Lymphoblastic Leukemia - Philadelphia Chromosome Positive Adult Precursor Acute Lymphoblastic Leukemia - R
Location: Baltimore, Maryland
- Bortezomib and Combination Chemotherapy in Treating Young Patients With Relapsed Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma
Conditions: Leukemia - Lymphoma
Location: Falls Church, Virginia
- Collecting Tissue Samples From Patients With Leukemia or Other Blood Disorders Planning to Enroll in an ECOG Leukemia Treatment Clinical Trial
Conditions: Leukemia - Lymphoma
Location: York, Pennsylvania
- Collecting and Storing Malignant, Borderline Malignant Neoplasms, and Related Samples From Young Patients With Cancer
Conditions: Leukemia - Neoplasm of Uncertain Malignant Potential - Unspecified Childhood Solid Tumor, Protocol Specific
Location: Falls Church, Virginia
- Phase II Trial of LMB-2, Fludarabine and Cyclophosphamide for Adult T-Cell Leukemia
Conditions: Adult T-Cell Leukemia (ATL)
Location: Bethesda, Maryland
- Phase I/II Study of B Cell Malignancies Using T Cells Expressing an Anti-CD19 Chimeric Receptor: Assessment of the Impact of Lymphocyte Depletion Prio
Conditions: Chronic Lymphocytic Leukemia - Small Lymphocytic Lymphoma - Mantle Cell Lymphoma - Follicular Lymphoma - Large Cell Lymphoma
Location: Bethesda, Maryland
- Clofarabine or Daunorubicin Hydrochloride and Cytarabine Followed By Decitabine or Observation in Treating Older Patients With Newly Diagnosed Acute M
Conditions: Leukemia
Location: York, Pennsylvania
- Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Conditions: Chronic Lymphocytic Leukemia
Location: Arlington, Virginia
- Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Conditions: Chronic Lymphocytic Leukemia
Location: Fairfax, Virginia
- Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Conditions: Chronic Lymphocytic Leukemia
Location: Leesburg, Virginia
- Entinostat and Clofarabine in Treating Patients With Newly Diagnosed, Relapsed, or Refractory Poor-Risk Acute Lymphoblastic Leukemia or Bilineage/Biph
Conditions: Acute Leukemias of Ambiguous Lineage - Philadelphia Chromosome Negative Adult Precursor Acute Lymphoblastic Leukemia - Recurrent Adult Acute Lymphoblastic Leukemia - Untreated Adult Acute Lymphoblastic Leukemia
Location: Baltimore, Maryland
- Entinostat and Clofarabine in Treating Patients With Newly Diagnosed, Relapsed, or Refractory Poor-Risk Acute Lymphoblastic Leukemia or Bilineage/Biph
Conditions: Acute Leukemias of Ambiguous Lineage - Philadelphia Chromosome Negative Adult Precursor Acute Lymphoblastic Leukemia - Recurrent Adult Acute Lymphoblastic Leukemia - Untreated Adult Acute Lymphoblastic Leukemia
Location: Baltimore, Maryland
- Risk-Based Classification System of Patients With Newly Diagnosed Acute Lymphoblastic Leukemia
Conditions: Leukemia
Location: Falls Church, Virginia
- Busulfan, Fludarabine Phosphate, and Anti-Thymocyte Globulin Followed By Donor Stem Cell Transplant and Azacitidine in Treating Patients With High-Ris
Conditions: Adult Acute Megakaryoblastic Leukemia (M7) - Adult Acute Minimally Differentiated Myeloid Leukemia (M0) - Adult Acute Monoblastic Leukemia (M5a) - Adult Acute Monocytic Leukemia (M5b) - Adult Acute Myeloblastic Leukemia With Maturation (M2) - Adult Acute
Location: Baltimore, Maryland
- Busulfan, Fludarabine Phosphate, and Anti-Thymocyte Globulin Followed By Donor Stem Cell Transplant and Azacitidine in Treating Patients With High-Ris
Conditions: Adult Acute Megakaryoblastic Leukemia (M7) - Adult Acute Minimally Differentiated Myeloid Leukemia (M0) - Adult Acute Monoblastic Leukemia (M5a) - Adult Acute Monocytic Leukemia (M5b) - Adult Acute Myeloblastic Leukemia With Maturation (M2) - Adult Acute
Location: Elkton MD, Maryland
- Risk-Adapted Chemotherapy in Younger Patients With Newly Diagnosed Standard-Risk Acute Lymphoblastic Leukemia
Conditions: Leukemia
Location: Falls Church, Virginia
- Randomized Study of ON 01910.Na in Refractory Myelodysplastic Syndrome Patients With Excess Blasts
Conditions: Myelodysplastic Syndromes - MDS - RAEB - Chronic Myelomonocytic Leukemia
Location: Baltimore, Maryland
- Randomized Study of ON 01910.Na in Refractory Myelodysplastic Syndrome Patients With Excess Blasts
Conditions: Myelodysplastic Syndromes - MDS - RAEB - Chronic Myelomonocytic Leukemia
Location: Baltimore, Maryland
- Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting
Conditions: Chronic Myeloid Leukemia
Location: York, Pennsylvania
- Sorafenib Tosylate and Chemotherapy in Treating Older Patients With Acute Myeloid Leukemia
Conditions: Adult Acute Megakaryoblastic Leukemia (M7) - Adult Acute Minimally Differentiated Myeloid Leukemia (M0) - Adult Acute Myeloblastic Leukemia Without Maturation (M1) - Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities - Adult Acute Myeloid Leukemi
Location: Baltimore, Maryland
- Sorafenib Tosylate and Chemotherapy in Treating Older Patients With Acute Myeloid Leukemia
Conditions: Adult Acute Megakaryoblastic Leukemia (M7) - Adult Acute Minimally Differentiated Myeloid Leukemia (M0) - Adult Acute Myeloblastic Leukemia Without Maturation (M1) - Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities - Adult Acute Myeloid Leukemi
Location: Elkton MD, Maryland
- Dasatinib Followed by Stem Cell Transplant in Treating Older Patients With Newly Diagnosed Acute Lymphoblastic Leukemia
Conditions: Philadelphia Chromosome Positive Adult Precursor Acute Lymphoblastic Leukemia - Untreated Adult Acute Lymphoblastic Leukemia
Location: Elkton MD, Maryland
- A Phase I Study of NK Cell Infusion Following Allogeneic Peripheral Blood Stem Cell Transplantation From Related or Matched Unrelated Donors in Pediat
Conditions: Leukemia - Lymphoma - Neuroblastoma - Sarcoma - Desmoplastic Small Round Cell Tumor
Location: Bethesda, Maryland
- Caspofungin Acetate or Fluconazole in Preventing Invasive Fungal Infections in Patients With Acute Myeloid Leukemia Who Are Undergoing Chemotherapy
Conditions: Fungal Infection - Leukemia - Neutropenia
Location: Falls Church, Virginia
- Pilot Study of Lupron to Improve Immune Function After Allogeneic Bone Marrow Transplantation
Conditions: Acute Lymphocytic Leukemia - Acute Myelogenous Leukemia - Myelodysplastic Syndrome RAEB 1
Location: Bethesda, Maryland
- Bortezomib and Sorafenib Tosylate in Patients With Newly Diagnosed Acute Myeloid Leukemia With or Without Mutations
Conditions: Adult Acute Erythroid Leukemia (M6) - Adult Acute Megakaryoblastic Leukemia (M7) - Adult Acute Minimally Differentiated Myeloid Leukemia (M0) - Adult Acute Monoblastic Leukemia (M5a) - Adult Acute Monocytic Leukemia (M5b) - Adult Acute Myeloblastic Leukem
Location: Falls Church, Virginia
- Combination Chemotherapy in Treating Young Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia
Conditions: Cognitive/Functional Effects - Leukemia - Neurotoxicity - Pain - Therapy-related Toxicity
Location: Falls Church, Virginia
- Alvocidib (Flavopiridol), Ara-C and Mitoxantrone (FLAM) Versus "7+3" for Newly (AML)
Conditions: Acute Myelogenous Leukemia
Location: Baltimore, Maryland
- Anti-Tac(90 Y-HAT) to Treat Hodgkin's Disease, Non-Hodgkin's Lymphoma and Lymphoid Leukemia
Conditions: Cutaneous T Cell Lymphoma - Hodgkin's Disease - Neoplasm - Non Hodgkin's Lymphoma - Peripheral T Cell Lymphoma
Location: Bethesda, Maryland
- Brentuximab Vedotin in Patients With CD30-positive Nonlymphomatous Malignancies
Conditions: Acute Lymphoid Leukemia - Acute Myeloid Leukemia - Chronic Lymphocytic Leukemia - Multiple Myeloma - Solid Tumors
Location: Fairfax, Virginia
- Azacitidine With or Without Lenalidomide or Vorinostat in Patients With Higher-Risk Myelodysplastic Syndromes or Chronic Myelomonocytic Leukemia
Conditions: Chronic Myelomonocytic Leukemia - de Novo Myelodysplastic Syndromes - Previously Treated Myelodysplastic Syndromes - Refractory Anemia With Excess Blasts - Secondary Myelodysplastic Syndromes
Location: Baltimore, Maryland
- Azacitidine With or Without Lenalidomide or Vorinostat in Patients With Higher-Risk Myelodysplastic Syndromes or Chronic Myelomonocytic Leukemia
Conditions: Chronic Myelomonocytic Leukemia - de Novo Myelodysplastic Syndromes - Previously Treated Myelodysplastic Syndromes - Refractory Anemia With Excess Blasts - Secondary Myelodysplastic Syndromes
Location: Elkton MD, Maryland
- A Randomized, Double-Blind and Placebo-Controlled Study of Idelalisib in Combination With Rituximab for Previously Treated Chronic Lymphocytic Leukemi
Conditions: Chronic Lymphocytic Leukemia
Location: Fairfax, Virginia
- A Extension Study of Idelalisib for Patients With Chronic Lymphocytic Leukemia Who Participated in GS-US-312-0116
Conditions: Chronic Lymphocytic Leukemia
Location: Fairfax, Virginia
- An Open Label Study to Evaluate the Safety and Efficacy of Two Doses of Quizartinib in Patients With Relapsed or Refractory Acute Myeloid Leukemia
Conditions: Leukemia, Myeloid, Acute
Location: Baltimore, Maryland
- An Open Label Study to Evaluate the Safety and Efficacy of Two Doses of Quizartinib in Patients With Relapsed or Refractory Acute Myeloid Leukemia
Conditions: Leukemia, Myeloid, Acute
Location: Baltimore, Maryland
- SC-PEG Asparaginase vs. Oncaspar in Pediatric Acute Lymphoblastic Leukemia (ALL) and Lymphoblastic Lymphoma
Conditions: Acute Lymphoblastic Leukemia - Lymphoblastic Lymphoma
Location: Falls Church, Virginia
- Anti-CD19 White Blood Cells for Children and Young Adults With B Cell Leukemia or Lymphoma
Conditions: ALL - B Cell Lymphoma - Leukemia - Large Cell Lymphoma - Non-Hodgkin Lymphoma
Location: Bethesda, Maryland
- KW 0761 or Investigator's Choice in Subjects With Previously Treated Adult T-cell Leukemia-Lymphoma (ATL)
Conditions: Adult T-cell Leukemia-Lymphoma
Location: Bethesda, Maryland
- Clofarabine Followed By Lenalidomide for High-Risk Myelodysplastic Syndromes and Acute Myeloid Leukemia
Conditions: Myeldysplastic Syndrome (MDS) - Chronic Myelomonocytic Leukemia - Bone Marrow Diseases - Neutropenia - Acute Myeloid Leukemia (AML)
Location: Bethesda, Maryland
- A Study of CSL362 in Patients With CD123+ Acute Myeloid Leukemia Currently in Remission
Conditions: Leukemia, Myeloid, Acute
Location: Baltimore, Maryland
- Romidepsin in Treating Patients With Lymphoma, Chronic Lymphocytic Leukemia, or Solid Tumors With Liver Dysfunction
Conditions: Adult Nasal Type Extranodal NK/T-cell Lymphoma - Anaplastic Large Cell Lymphoma - Angioimmunoblastic T-cell Lymphoma - Cutaneous B-cell Non-Hodgkin Lymphoma - Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue - Hepatic Complica
Location: Baltimore, Maryland
- Romidepsin in Treating Patients With Lymphoma, Chronic Lymphocytic Leukemia, or Solid Tumors With Liver Dysfunction
Conditions: Adult Nasal Type Extranodal NK/T-cell Lymphoma - Anaplastic Large Cell Lymphoma - Angioimmunoblastic T-cell Lymphoma - Cutaneous B-cell Non-Hodgkin Lymphoma - Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue - Hepatic Complica
Location: Bethesda, Maryland
- Validating Pain Scales in Children and Young Adults
Conditions: Solid Tumor - Leukemia - Neurofibromatosis
Location: Bethesda, Maryland
- A Study of Erwinaze Administered Intravenously in Patients Who Had an Allergy to Frontline Asparaginase Therapy
Conditions: Acute Lymphoblastic Leukemia - Lymphoblastic Lymphoma
Location: Falls Church, Virginia
- A Study of Erwinaze Administered Intravenously in Patients Who Had an Allergy to Frontline Asparaginase Therapy
Conditions: Acute Lymphoblastic Leukemia - Lymphoblastic Lymphoma
Location: Baltimore, Maryland
- Ponatinib in Newly Diagnosed Chronic Myeloid Leukemia (CML) (EPIC)
Conditions: Chronic Myeloid Leukemia
Location: Baltimore, Maryland
- Ponatinib in Newly Diagnosed Chronic Myeloid Leukemia (CML) (EPIC)
Conditions: Chronic Myeloid Leukemia
Location: Baltimore, Maryland
- An Extension Study of RO5045337 in Patients Participating in Previous Cancer Studies
Conditions: Myelogenous Leukemia, Chronic, Neoplasms, Myelogenous Leukemia, Acute
Location: Rockville, Maryland
- A Phase II, Single Arm, Open Label Study of Treatment-free Remission After Achieving Sustained MR4.5 on Nilotinib (ENESTop)
Conditions: Chronic Myeloid Leukemia
Location: Baltimore, Maryland
- Study of the Efficacy and Safety of Ublituximab in Patients With Relapsed or Refractory B-cell Non-Hodgkin Lymphoma
Conditions: Non-Hodgkins Lymphoma - B-cell Lymphoma - Waldenstrom's Macroglobulinemia - Marginal Zone Lymphoma - Chronic Lymphocytic Leukemia - Small Lymphocytic Lymphoma - Primary Central Nervous System Lymphoma
Location: Bethesda, Maryland
- A Phase 2 of GS-9973 in Subjects With Relapsed or Refractory Hematologic Malignancies
Conditions: Chronic Lymphocytic Leukemia - Mantle Cell Lymphoma - Diffuse Large B-cell Lymphoma - Indolent Non-Hodgkin's Lymphoma
Location: Fairfax, Virginia
- Moxetumomab Pasudotox for Advanced Hairy Cell Leukemia
Conditions: Leukemia, Hairy Cell
Location: Bethesda, Maryland
- Sorafenib in Treating Young Patients With Relapsed or Refractory Solid Tumors or Leukemia
Conditions: Leukemia - Unspecified Childhood Solid Tumor, Protocol Specific
Location: Washington, District of Columbia
- Glutamic Acid in Reducing Nerve Damage Caused by Vincristine in Young Patients Receiving Vincristine for Wilms' Tumor, Rhabdomyosarcoma, Acute Lymphob
Conditions: Kidney Cancer - Leukemia - Lymphoma - Neurotoxicity - Peripheral Neuropathy - Sarcoma
Location: Washington, District of Columbia
- Low-Dose or High-Dose Vincristine and Combination Chemotherapy in Treating Young Patients With Relapsed B-Cell Acute Lymphoblastic Leukemia
Conditions: Leukemia
Location: Washington, District of Columbia
- Low-Dose or High-Dose Vincristine and Combination Chemotherapy in Treating Young Patients With Relapsed B-Cell Acute Lymphoblastic Leukemia
Conditions: Leukemia
Location: Washington, District of Columbia
- Tacrolimus and Methotrexate With or Without Sirolimus in Preventing Graft-Versus-Host Disease in Young Patients Undergoing Donor Stem Cell Transplant
Conditions: Graft Versus Host Disease - Leukemia
Location: Washington, District of Columbia
- Combination Chemotherapy in Treating Young Patients With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia or T-cell Lymphoblastic Lymphoma
Conditions: Contiguous Stage II Adult Lymphoblastic Lymphoma - Noncontiguous Stage II Adult Lymphoblastic Lymphoma - Stage II Adult T-cell Leukemia/Lymphoma - Stage II Childhood Lymphoblastic Lymphoma - Stage III Adult Lymphoblastic Lymphoma - Stage III Adult T-cell
Location: Washington, District of Columbia
- Combination Chemotherapy in Treating Young Patients With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia or T-cell Lymphoblastic Lymphoma
Conditions: Contiguous Stage II Adult Lymphoblastic Lymphoma - Noncontiguous Stage II Adult Lymphoblastic Lymphoma - Stage II Adult T-cell Leukemia/Lymphoma - Stage II Childhood Lymphoblastic Lymphoma - Stage III Adult Lymphoblastic Lymphoma - Stage III Adult T-cell
Location: Washington, District of Columbia
- Donor Stem Cell Transplant in Treating Young Patients With Acute Myeloid Leukemia With Monosomy 7, -5/5q-, High FLT3-ITD AR, or Refractory or Relapsed
Conditions: Leukemia
Location: Washington, District of Columbia
- Combination Chemotherapy With or Without Lestaurtinib in Treating Infants With Newly Diagnosed Acute Lymphoblastic Leukemia
Conditions: Leukemia
Location: Washington, District of Columbia
- Combination Chemotherapy With or Without Lestaurtinib in Treating Infants With Newly Diagnosed Acute Lymphoblastic Leukemia
Conditions: Leukemia
Location: Washington, District of Columbia
- Bortezomib and Combination Chemotherapy in Treating Young Patients With Relapsed Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma
Conditions: Leukemia - Lymphoma
Location: Washington, District of Columbia
- Bortezomib and Combination Chemotherapy in Treating Young Patients With Relapsed Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma
Conditions: Leukemia - Lymphoma
Location: Washington, District of Columbia
- Collecting and Storing Samples of Bone Marrow and Blood From Patients With Relapsed Acute Lymphoblastic Leukemia or Non-Hodgkin Lymphoma
Conditions: Leukemia - Lymphoma
Location: Washington, District of Columbia
- Collecting and Storing Samples of Bone Marrow and Blood From Patients With Relapsed Acute Lymphoblastic Leukemia or Non-Hodgkin Lymphoma
Conditions: Leukemia - Lymphoma
Location: Washington, District of Columbia
- Collecting and Storing Malignant, Borderline Malignant Neoplasms, and Related Samples From Young Patients With Cancer
Conditions: Leukemia - Neoplasm of Uncertain Malignant Potential - Unspecified Childhood Solid Tumor, Protocol Specific
Location: Washington, District of Columbia
- Collecting and Storing Malignant, Borderline Malignant Neoplasms, and Related Samples From Young Patients With Cancer
Conditions: Leukemia - Neoplasm of Uncertain Malignant Potential - Unspecified Childhood Solid Tumor, Protocol Specific
Location: Washington, District of Columbia
- Collecting and Storing Blood, Bone Marrow, and Other Samples From Patients With Acute Leukemia, Chronic Leukemia, or Myelodysplastic Syndromes
Conditions: Leukemia - Lymphoma - Myelodysplastic Syndromes - Myelodysplastic/Myeloproliferative Neoplasms
Location: Washington, District of Columbia
- Collecting and Storing Blood, Bone Marrow, and Other Samples From Patients With Acute Leukemia, Chronic Leukemia, or Myelodysplastic Syndromes
Conditions: Leukemia - Lymphoma - Myelodysplastic Syndromes - Myelodysplastic/Myeloproliferative Neoplasms
Location: Washington, District of Columbia
- Studying Tissue and Blood Samples From Patients With Acute Myeloid Leukemia
Conditions: Leukemia
Location: Washington, District of Columbia
- Study of Blood Samples From Newborns With Down Syndrome
Conditions: Leukemia
Location: Washington, District of Columbia
- Study of Biomarkers in Blood and Bone Marrow Samples From Patients With Previously Untreated Chronic Lymphocytic Leukemia
Conditions: Leukemia
Location: Washington, District of Columbia
- Risk-Based Classification System of Patients With Newly Diagnosed Acute Lymphoblastic Leukemia
Conditions: Leukemia
Location: Washington, District of Columbia
- Risk-Based Classification System of Patients With Newly Diagnosed Acute Lymphoblastic Leukemia
Conditions: Leukemia
Location: Washington, District of Columbia
- MLN8237 in Treating Young Patients With Recurrent or Refractory Solid Tumors or Leukemia
Conditions: Brain and Central Nervous System Tumors - Childhood Germ Cell Tumor - Kidney Cancer - Leukemia - Liver Cancer - Neuroblastoma - Sarcoma
Location: Washington, District of Columbia
- MLN8237 in Treating Young Patients With Recurrent or Refractory Solid Tumors or Leukemia
Conditions: Brain and Central Nervous System Tumors - Childhood Germ Cell Tumor - Kidney Cancer - Leukemia - Liver Cancer - Neuroblastoma - Sarcoma
Location: Washington, District of Columbia
- INCB18424 in Treating Young Patients With Relapsed or Refractory Solid Tumor, Leukemia, or Myeloproliferative Disease
Conditions: Chronic Myeloproliferative Disorders - Leukemia - Myelodysplastic Syndromes - Myelodysplastic/Myeloproliferative Neoplasms - Unspecified Childhood Solid Tumor, Protocol Specific
Location: Washington, District of Columbia
- Risk-Adapted Chemotherapy in Younger Patients With Newly Diagnosed Standard-Risk Acute Lymphoblastic Leukemia
Conditions: Leukemia
Location: Washington, District of Columbia
- Risk-Adapted Chemotherapy in Younger Patients With Newly Diagnosed Standard-Risk Acute Lymphoblastic Leukemia
Conditions: Leukemia
Location: Washington, District of Columbia
- Study of Vosaroxin or Placebo in Combination With Cytarabine in Patients With First Relapsed or Refractory Acute Myeloid Leukemia (AML)
Conditions: Leukemia - Acute Myeloid Leukemia - Acute Nonlymphocytic Leukemia
Location: Washington, District of Columbia
- A Study of the Safety and Pharmacokinetics of Escalating Doses of DCDT2980S in Patients With Relapsed or Refractory B-Cell Non-Hodgkin's Lymphoma and
Conditions: Non-Hodgkin's Lymphoma, Chronic Lymphocytic Leukemia
Location: Washington, District of Columbia
- Randomized Study of ON 01910.Na in Refractory Myelodysplastic Syndrome Patients With Excess Blasts
Conditions: Myelodysplastic Syndromes - MDS - RAEB - Chronic Myelomonocytic Leukemia
Location: Washington, District of Columbia
- Caspofungin Acetate or Fluconazole in Preventing Invasive Fungal Infections in Patients With Acute Myeloid Leukemia Who Are Undergoing Chemotherapy
Conditions: Fungal Infection - Leukemia - Neutropenia
Location: Washington, District of Columbia
- Levofloxacin in Preventing Infection in Young Patients Receiving Chemotherapy For Acute Leukemia or Undergoing Stem Cell Transplantation
Conditions: Bacterial Infection - Leukemia - Musculoskeletal Complications - Neutropenia
Location: Washington, District of Columbia
- MRD Testing Before and After Hematopoietic Cell Transplantation Transplantation for Pediatric Acute Myeloid Leukemia
Conditions: Acute Myeloid Leukemia
Location: Washington, District of Columbia
- Temsirolimus, Dexamethasone, Mitoxantrone Hydrochloride, Vincristine Sulfate, and Pegaspargase in Treating Young Patients With Relapsed Acute Lymphobl
Conditions: B-cell Childhood Acute Lymphoblastic Leukemia - Peripheral T-cell Lymphoma - Recurrent Childhood Acute Lymphoblastic Leukemia - Recurrent Childhood Lymphoblastic Lymphoma - T-cell Childhood Acute Lymphoblastic Leukemia
Location: Washington, District of Columbia
- Combination Chemotherapy in Treating Young Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia
Conditions: Cognitive/Functional Effects - Leukemia - Neurotoxicity - Pain - Therapy-related Toxicity
Location: Washington, District of Columbia
- Combination Chemotherapy in Treating Young Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia
Conditions: Cognitive/Functional Effects - Leukemia - Neurotoxicity - Pain - Therapy-related Toxicity
Location: Washington, District of Columbia
- Decitabine With or Without Bortezomib in Treating Older Patients With Acute Myeloid Leukemia
Conditions: Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic Syndrome - Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities - Adult Acute Myeloid Leukemia With Del(5q) - Adult Acute Myeloid Leukemia With t(16;16)(p13;q22) - Seconda
Location: Washington, District of Columbia
- Pediatric Philadelphia Positive Acute Lymphoblastic Leukemia
Conditions: Leukemia, Pediatric
Location: Washington, District of Columbia
- Alisertib in Treating Patients With Relapsed or Refractory Peripheral T-Cell Non-Hodgkin Lymphoma
Conditions: Adult Nasal Type Extranodal NK/T-cell Lymphoma - Anaplastic Large Cell Lymphoma - Angioimmunoblastic T-cell Lymphoma - Hepatosplenic T-cell Lymphoma - Peripheral T-cell Lymphoma - Recurrent Adult Non-Hodgkin Lymphoma - Recurrent Adult T-cell Leukemia/Lymp
Location: Washington, District of Columbia
- Study Assessing Compliance With Mercaptopurine Treatment in Younger Patients With Acute Lymphoblastic Leukemia in First Remission
Conditions: Leukemia
Location: Washington, District of Columbia
- A Randomized, Double-Blind and Placebo-Controlled Study of Idelalisib in Combination With Rituximab for Previously Treated Chronic Lymphocytic Leukemi
Conditions: Chronic Lymphocytic Leukemia
Location: Washington, District of Columbia
- A Extension Study of Idelalisib for Patients With Chronic Lymphocytic Leukemia Who Participated in GS-US-312-0116
Conditions: Chronic Lymphocytic Leukemia
Location: Washington, District of Columbia
- Cediranib Maleate in Treating Patients With Relapsed, Refractory, or Untreated Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome
Conditions: Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities - Adult Acute Myeloid Leukemia With Inv(16)(p13;q22) - Adult Acute Myeloid Leukemia With t(15;17)(q22;q12) - Adult Acute Myeloid Leukemia With t(16;16)(p13;q22) - Adult Acute Myeloid Leukemia Wit
Location: Washington, District of Columbia
|